61 Results found.
In an issue brief prepared for The Commonwealth Fund and The SCAN Foundation, HMA consultant Jennifer Podulka and Vice President Jonathan Blum, analyze the temporary COVID-19-related changes to Medicare regulations, described the benefits and risks of the changes, and offered a framework to support policymakers’ decisions on the future of these temporary policies.
A new Issue Brief, authored by Jennifer Podulka and Jon Blum, examines the many changes to Medicare regulations put in place during the COVID-19 pandemic. The brief, Which Medicare Changes Should Continue Beyond the COVID-19 Pandemic? Four Questions for Policymakers, tracks and categorizes the regulatory changes, describes the benefits and risks of the changes, and establishes a framework to support policymakers’ decisions regarding the future for the changes after the pandemic ends.
HMA has published a white paper identifying the appropriate, and inappropriate, uses of risk corridors in the context of Medicaid managed care capitation rate setting. The paper is timely due to the widespread use of risk corridors by states during the COVID-19 public health emergency (PHE) and the potential continuation of those risk corridors after the PHE ends.
Download the Executive Summary here.
This webinar was held on March 16, 2021.
COVID-19 vaccination has lagged among underserved populations and communities of color in part because of a deeply rooted historical skepticism concerning the safety and efficacy of certain medical treatments and procedures. During this webinar, experts from HMA, Tufts Health Plan, and ConsejoSano discussed how healthcare providers and public health officials can engage underserved populations and communities of color, build trust through tailored strategies, and raise the level of comfort and confidence among individuals still reticent to receive the COVID-19 vaccine.
- Understand the drivers of lagging COVID-19 vaccination rates among underserved populations and communities of color.
- Find out how to build confidence in the safety and efficacy of COVID-19 vaccines using strategies tailored to specific populations and specific healthcare settings.
- Understand the special challenges and promising strategies for increasing vaccine confidence among individuals with behavioral health issues.
- Explore a novel high-tech, high-touch multicultural engagement solution for tailoring vaccine confidence strategies to diverse populations.
- Learn how to tackle underlying health equity challenges that might hinder efforts to improve COVID vaccination rates among underserved populations and communities of color.
Margaret Kirkegaard, MD, Principal, HMA
Karen Hill, Senior Consultant, HMA
Deb Peartree, Senior Consultant, HMA
Gary Rosenfield, SVP of Business Development & Strategy, ConsejoSano
Juan Lopera, Corporate Business Diversity Officer, VP of Marketing & RI Medicaid, Tufts Health Plan